Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Phase 2
120
about 2 years
5–20
1 site in CA
What this study is about
This trial is testing if a low dose of ketamine helps with pain caused by sickle cell disease. It compares the effects of ketamine plus standard pain medicine to standard pain medicine alone.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Normal Saline Placebo Infusion
- 2.Receive Sub-dissociative Ketamine Infusion
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
anesthetic (NMDA receptor antagonist; induces dissociative anesthesia and analgesia)
infusion
Secondary: ED Length of Stay, Pain Score, Quality of Life (Pediatric Quality of Life), Rate of Hospitalization